Yahoo Finance16d
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES DETAILS OF LACRIFILL® CANALICULAR GEL POSTER PRESENTATION AT SECO 2025
BERWYN, Pa., Feb. 28, 2025 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced today a poster presentation at SECO 2025 being held from February 26 – March 2 in ...
Endpoints News11d
Bavar­i­an Nordic CEO says it can take years to move phar­ma man­u­fac­tur­ing to the US
Bavarian Nordic CEO Paul Chaplin warns US pharma reshoring could take 5-10 years, citing tech transfer complexities. Company ...
FiercePharma26d
Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine approval from FDA
Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. The Danish company’s chikungunya vaccine, Vimkunya, has now crossed the FDA finish line, heating up the ...
Finanznachrichten16d
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces Details Of Lacrifill Canalicular Gel Poster Presentation At Seco 2025
BERWYN, Pa., Feb. 28, 2025 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced today a poster presentation at SECO 2025 being held from February 26 - March 2 in ...
Yahoo Finance16d
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES DETAILS OF LACRIFILL® CANALICULAR GEL POSTER PRESENTATION AT SECO 2025
BERWYN, Pa., Feb. 28, 2025 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced today a poster presentation at SECO 2025 being held from February 26 – March 2 in Atlanta, ...